After completing the CME activity, learners should be better able to:
-Recognize the importance of an early differential diagnosis of Alzheimer’s disease to allow for early disease management or referral
-Describe current understanding of AD pathophysiology and review the use of cognitive and neuroimaging tests as part of a comprehensive evaluation for the early diagnosis of mild Alzheimer’s disease
-Discuss current and emerging therapeutic targets, and new data on investigational agents for treatment of mild AD with a disease-modifying approach to delay or slow AD progression